Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Virtual Congress 2020

EONS13: Phase I clinical trials: What does this mean for our patients?

Why do we need phase I clinical trials?

Date

20 Sep 2020

Session

EONS13: Phase I clinical trials: What does this mean for our patients?

Topics

Clinical Research

Tumour Site

Presenters

Martijn Lolkema

Authors

M.P. Lolkema

Author affiliations

  • Medical Oncology, Erasmus University Medical Center, 3015 CE - Rotterdam/NL

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Q&A live discussion

Presenter: Ruben Martin Payo

Session: EONS13: Phase I clinical trials: What does this mean for our patients?

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.